Sheng Hou
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Sheng Hou currently works at Mabpharm Ltd., as Executive Director & Vice President from 2023, Taizhou Mabtech Pharmaceutical Co. Ltd., as Director from 2023, and Shanghai Shengheng Biotechnology Ltd., as Director from 2023.
Dr. Hou also formerly worked at Wuhan Guojian Baiao Pharmaceutical Co. Ltd., as Chairman & General Manager from 2021 to 2023.
Dr. Hou received his undergraduate degree in 2000 from The Second Military Medical University and graduate degree in 2002 and doctorate degree in 2005 from The Second Military Medical University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MABPHARM LIMITED -.--% | 30/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MABPHARM LIMITED | Director/Miembro de la Junta | 28/11/2023 |
Taizhou Mabtech Pharmaceutical Co. Ltd. | Director/Miembro de la Junta | 01/11/2023 |
| Empresas | Cargo | Fin |
|---|
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
The Second Military Medical University
The Second Military Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mabpharm Ltd.
Mabpharm Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company develops pipeline contains to treat cancer and autoimmune diseases | Commercial Services |
Taizhou Mabtech Pharmaceutical Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.